Apalutamide
Back to search| Scientific Name: | Apalutamide |
| Brand Name: | Erleada |
| Company Owner: | Not Available |
| Mechanism Of Action | Persistent androgen receptor (AR) signaling is a common feature of castration-resistant prostate cancer (CRPC) , attributed to AR gene-amplification, AR gene mutation, increased AR expression or increased androgen biosynthesis in prostate tumors |
| Description of the Drug: | Apalutamide is an androgen receptor inhibitor used to treat non metastatic, castration resistant prostate cancer. |
| Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB11901
